Loading clinical trials...
Loading clinical trials...
Evaluation of the Benefits of Oral Metronomic Cyclophosphamide in Combination With Standard Cisplatin-etoposide Based Chemotherapy for Squamous Cell Lung Carcinoma
Conditions
Interventions
Intravenous Cisplatin & etoposide
Intravenous Cisplatin & etoposide along with oral cyclophosphamide
Locations
1
India
Swami Rama Cancer Hospital & Research Institute
Haldwani, Nainital, Uttarakhand, India
Start Date
October 1, 2013
Primary Completion Date
June 1, 2014
Completion Date
October 1, 2014
Last Updated
September 20, 2013
NCT05198830
NCT06066138
NCT06498635
NCT07485114
NCT07336732
NCT07190248
Lead Sponsor
Swami Rama Cancer Hospital and Research Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions